Veracyte Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis
Go back to Veracyte Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis| VERACYTE (NASDAQ: VCYT) | Delayed: 54.01 +0.82 (1.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.19 | 52 Week High | $8.45 | |||
| Open | $52.79 | 52 Week Low | $4.21 | |||
| Day High | $54.12 | P/E | N/A | |||
| Day Low | $52.65 | EPS | $-1.52 | |||
| Volume | 49,380 | |||||
